Skip to main content
CORCencora, Inc.Sell5.4·$354.00

Cencora (COR) Q3 2026 earnings — TrendMatrix coverage

BEAT+1.9% vs estimateEPS $4.66 vs $4.57 estCurrent verdict Sell 5.4/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy

Event detail · Q3 2026

Key numbers

Adjusted EPS
$4.66
Estimate
$4.57
Surprise
+1.9%
Score today
5.4/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Report record · Q3 2026

How the report landed

Cencora (COR) beat the $4.57 estimate with adjusted EPS of $4.66 — a modest 1.9% upside surprise.

Around the report

Coverage in the report window

  • Cencora Q4 2026 Earnings Call Transcript — benzinga, 2026-11-04
  • Cencora Reports Fiscal Q4 2026 Results and Provides Fiscal 2027 Guidance — fiscal.ai, 2026-11-04
  • Cencora Consolidates Specialty Businesses Under New Leadership — fiscal.ai, 2026-11-04
Current read · as of 2026-11-05

Where TrendMatrix's rating stands now

TrendMatrix currently rates COR Sell at 5.4/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +1.9% surprise compares with a +1.6% four-quarter average.

What argues against it

  • Concentration risk — Customer: top ten customers (66.0%)
  • Target reached (-8.7% upside)
  • Quality below floor (3.9 < 4.0)

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$354.00
Stop
$338.52

The stock trades at 19.7× trailing but 16.1× forward earnings — consensus estimates already build in a substantial earnings recovery.

Risk check: trading volume is running 2.2× its average — elevated turnover around the report window.

Model outputs from TrendMatrix’s engine as of 2026-11-05 — shown for context, not personalized investment advice.

Healthcare context

COR at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Distribution
Market cap
$67.55B
P/E (fwd)
16.1
P/E (ttm)
19.7
52-week range
$244.82–$377.54
Off 52-week high
6.2%
RSI (14)
62
Volume vs avg
2.23×
Score today
5.4/10

EPS and the estimate come from Yahoo Finance’s earnings calendar, captured around the report date. That EPS is the adjusted figure analysts forecast, so it can differ from the GAAP diluted EPS in the company’s filing, and consensus estimates vary between data providers. Revenue comes from SEC XBRL company facts where available, yfinance-provisional otherwise. Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home › Stocks › COR › Earnings › Q3 2026 earnings